Production (Stage)
BioAtla, Inc.
BCAB
$0.391
$0.00140.36%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -61.88M | -69.78M | -81.82M | -104.56M | -119.24M |
| Total Depreciation and Amortization | 868.00K | 925.00K | 1.07M | 1.11M | 1.17M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.58M | 8.11M | 9.73M | 11.05M | 12.23M |
| Change in Net Operating Assets | -1.97M | -11.20M | -14.05M | -14.89M | -6.35M |
| Cash from Operations | -57.40M | -71.94M | -85.08M | -107.29M | -112.19M |
| Capital Expenditure | -- | -- | -8.00K | -33.00K | -48.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -8.00K | -33.00K | -48.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 9.56M | 9.56M | 393.00K | 407.00K | 336.00K |
| Repurchase of Common Stock | -62.00K | -46.00K | -76.00K | -117.00K | -156.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -366.00K | -- | -- | -- | -- |
| Cash from Financing | 9.13M | 9.51M | 317.00K | 290.00K | 180.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -48.27M | -62.43M | -84.77M | -107.03M | -112.06M |